TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MNPR

Monopar Therapeutics Inc

Healthcare · Biotechnology

102.70$ +1.2% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Monopar Therapeutics Inc (MNPR): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/11/2026.

Next report 08/11/2026
Last report 08/12/2026
Earnings surprise by quarter (%)
Q3 23 · 26.3 % 23 Q4 23 · 20.0 % 23 Q1 24 · 41.2 % 24 Q2 24 · -6.4 % 24 Q3 24 · -58.1 % 24 Q4 24 · -554.8 % 24 Q1 25 · 33.3 % 25 Q2 25 · 27.1 % 25 Q3 25 · -20.0 % 25 Q4 25 · -19.6 % 25 Q1 26 · 48.8 % 26 Q2 26 · 7.5 % 26

EPS estimate beaten

Full history 16 of 33 quarters (48%)
Last 16 quarters 10 of 16 quarters (63%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/12/2026 Monopar Therapeutics (MNPR): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/22/2026 Monopar Therapeutics (MNPR): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?